An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.
Active Trade on Social Networks
Separately, a robust trade exists on Telegram, where groups with numerous of participants share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals administering products of unknown origin.
Some professionals stated the popularity for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and customer regulations, risking penalties, prosecution or imprisonment.
Platform Reaction and Material Removal
Based on the social media company, the service has removed violative material and banned associated hashtags and search suggestions. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Research also found communities with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with photos of slimming results, glowing testimonials and detailed guides for preparing or injecting at residence.
Within moments of joining one community, a seller posted WhatsApp details, where most transactions take place. The seller provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.
Product Details and Costs
Inside these groups, posts show dark colored parcels with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When asked how long a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for the messaging service stated it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they can’t verify. Although the research behind this drug is sound, these digital versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already seen individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly serious health risks”.
